To All, I noticed that Michael Weiss, CEO of TG Therapeutics reduced his total share count considerably in 2016. He went from owning 4.5 million shares down to 1.1 million. Maybe he had to unload them by a certain date, I am not that familiar with shares owned by insiders. Just wanted to bring it […]
↧